Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene

J Virol. 1988 Oct;62(10):3914-7. doi: 10.1128/JVI.62.10.3914-3917.1988.

Abstract

Antiviral effects were characterized for two oligodeoxyribonucleoside methylphosphonates synthesized in an antisense (3'-TCTTAACC-5') or a sense (5'-AGAATTGG-3') orientation, based on the RNA sequence of the first splice acceptor site of the tat-3 gene of human immunodeficiency virus (HIV) (5'...AGAAUUGG...3'). The development of syncytial cells and supernatant reverse transcriptase was inhibited by a single exposure to the antisense HIV, and HIV RNA synthesis was inhibited by both antisense and sense methylphosphonates but not by a control herpes simplex virus antisense sequence.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cytopathogenic Effect, Viral
  • Deoxyribonucleotides / pharmacology*
  • Gene Products, tat
  • Genes, Viral / drug effects*
  • HIV / drug effects*
  • HIV / enzymology
  • HIV / genetics
  • HIV / physiology
  • Humans
  • Oligodeoxyribonucleotides*
  • RNA, Viral / biosynthesis
  • RNA, Viral / drug effects*
  • RNA-Directed DNA Polymerase / biosynthesis
  • Transcription Factors / genetics*
  • Virus Replication / drug effects
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Antiviral Agents
  • Deoxyribonucleotides
  • Gene Products, tat
  • Oligodeoxyribonucleotides
  • RNA, Viral
  • Transcription Factors
  • dideoxyribonucleoside methylphosphonates
  • tat Gene Products, Human Immunodeficiency Virus
  • RNA-Directed DNA Polymerase